Stem Cell Therapeutic and Research Reauthorization Act of 2026

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 4109 Introduced in Senate (IS)]

<DOC>

119th CONGRESS
  2d Session
                                S. 4109

To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and
                          for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             March 17, 2026

Mr. Reed (for himself, Mr. Scott of South Carolina, Ms. Smith, and Mr.
   Lankford) introduced the following bill; which was read twice and
  referred to the Committee on Health, Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL

To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and
                          for other purposes.

    Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Stem Cell Therapeutic and Research
Reauthorization Act of 2026''.

SEC. 2. REAUTHORIZATION OF THE C.W. BILL YOUNG CELL TRANSPLANTATION
              PROGRAM.

    Section 379B of the Public Health Service Act (42 U.S.C. 274m) is
amended--
            (1) by striking ``appropriated $31,009,000'' and inserting
        the following: ``appropriated--
            ``(1) $31,009,000'';
            (2) in paragraph (1), as so inserted, by striking the
        period at the end and inserting ``; and''; and
            (3) by adding at the end the following:
            ``(2) $33,009,000 for each of fiscal years 2027 through
        2031.''.

SEC. 3. CORD BLOOD INVENTORY.

    Section 2(g) of the Stem Cell Therapeutic and Research Act of 2005
(42 U.S.C. 274k note) is amended by striking ``2026'' and inserting
``2031''.
                                 <all>